Novo Nordisk A/S
看多

NVO hit downside price target

123
NVO just hit the downside price target with this recent market pullback, this momentum trend has been in effect since Nov 2022. I expect this to pick back up with a possible wick slightly lower than here. I think we see a retest to 142$ in the coming weeks. I am debating adding LEAPs on this bad boy but I think the company is overvalued, I do not fade these cult movers though.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。